$ONCY News Article - Oncolytics Biotech Collaborates with Roche and AIO to Initiate a Phase 1/2 Gastrointestinal Cancer Trial Combining Pelareorep with Roche's Anti-PD-L1 Checkpoint Inhibitor
https://marketwirenews.com/news-releases/onco...15906.html